Ikarian Capital, LLC - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 21 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q2 2022$237,000
-40.6%
61,433
-20.9%
0.04%
-17.3%
Q1 2022$399,000
+1.0%
77,650
+5.1%
0.05%
-11.9%
Q4 2021$395,000
-13.9%
73,8820.0%0.06%
+84.4%
Q3 2021$459,000
-49.2%
73,882
-50.7%
0.03%
-56.2%
Q2 2021$903,000
-38.7%
150,0000.0%0.07%
+46.0%
Q1 2021$1,472,000150,0000.05%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,028,253$1,8820.09%
Gradient Capital Advisors, LLC 26,808$49,0590.02%
WEST PACES ADVISORS INC. 1,665$3,0470.00%
DIMENSIONAL FUND ADVISORS LP 15,927$29,1470.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,382$4,3590.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$31,9950.00%
CITIGROUP INC 7$130.00%
MORGAN STANLEY 533$9750.00%
Rathbones Group PLC 14,000$25,6200.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders